Want to join the conversation?
Healthcare giant $JNJ reported a 2.4% decline in 4Q15 sales due to strong U.S. dollar, despite a rise in earnings. Net income rose to $3.22Bil or $1.15 per share from $2.52Bil or $0.89 per share last year. Sales fell to $17.81Bil from $18.25Bil. Adjusted EPS increased 5.1% to $1.44.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)